Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293213 · ClinicalTrials.gov registry record · NA
EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02293213 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 33 participants.
The verdict
NCT02293213, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Investigators propose a randomized controlled trial of women taking category D or X medications seen in family medicine, internal medicine or in the Coumadin Clinic. Women in the intervention group will receive an electronic medical record referral for teratogen counseling and contraceptive counseling with a follow up contraceptive provision appointment. The contraceptive counseling will be adapted from The Contraceptive CHOICE Project script and promote the use of the long acting reversible contraception. The women in the control group will also receive an electronic medical record referral and receive the teratogen counseling but only be told that it is important to avoid becoming pregnant. An initial survey will assess contraceptive knowledge and utilization. In addition, there will be telephone survey at 3 months and 6 months to assess contraceptive utilization and continuation.
Interventions
- BEHAVIORAL Baseline Questionnaire
- BEHAVIORAL EMR Referral
- BEHAVIORAL CTIS Counseling
- BEHAVIORAL Contraception Provision Appointment
- BEHAVIORAL 3 Month Follow Up Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293213
The ClinicalTrials.gov registry entry for NCT02293213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Baseline Questionnaire is the first listed.
NCT02293213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293213 about?
NCT02293213 is a clinical study titled "EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT". Investigators propose a randomized controlled trial of women taking category D or X medications seen in family medicine, internal medicine or in the Coumadin Clinic. Women in the intervention group will receive an electronic medical record referral for teratogen counseling and contraceptive counseli...
What is the current status of trial NCT02293213?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02293213?
The interventions under investigation include: Baseline Questionnaire (BEHAVIORAL), EMR Referral (BEHAVIORAL), CTIS Counseling (BEHAVIORAL), Contraception Provision Appointment (BEHAVIORAL), 3 Month Follow Up Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02293213?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.